Skip to Main Content

Paper Details

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
1
2023
-arrestin, GLP-1, GLP-1R, GLP1R, GLP1R variants, Human, Human GLP-1 Receptor, LoS variant, LoS variants, cAMP, cyclic adenosine monophosphate, glucagon-like peptide 1 receptor, glucose, glycated hemoglobin A1c, human, loss-of-signaling (LoS) variants, nonsynonymous, nonsynonymous GLP1R variants, nonsynonymous variants, pLoF variants, participants, patients, transfected cells, type 2 diabetes, wild
Author NameAffiliation
Jette Bork-JensenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Oluf PedersenCenter for Clinical Metabolic Research, Gentofte Hospital
Allan LinnebergUniversity of Copenhagen
Allan LinnebergCenter for Clinical Research and Prevention, Copenhagen University Hospital-Bispebjerg and Frederiksberg
Anette P GjesingNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Niels GrarupNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
  • 1 - 8

Datasets

Release 1.2